"Tatsuaki;Takeda|Shiho;Sugimoto|Jun;Matsumoto|Naohiro;Iwata|Akihiko;Nakamoto|Aya Fukuma;Ozaki|Hirofumi;Hamano|Noritaka;Ariyoshi|Yoshito;Zamami|","A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases","International Journal of Clinical Pharmacy","2210-7703","2024-01-19","","","","","isVersionOf https://doi.org/10.1007/s11096-023-01687-6","38240964","001145361500002","https://ousar.lib.okayama-u.ac.jp/66563","10.1007/s11096-023-01687-6"
    "Jun;Matsumoto|Anzu;Nishimoto|Shogo;Watari|Hideo;Ueki|Shoya;Shiromizu|Naohiro;Iwata|Tatsuaki;Takeda|Soichiro;Ushio|Makoto;Kajizono|Masachika;Fujiyoshi|Toshihiro;Koyama|Motoo;Araki|Koichiro;Wada|Yoshito;Zamami|Yasutomo;Nasu|Noritaka;Ariyoshi|","Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma","Molecular and Cellular Biochemistry","0300-8177","2022-12-26","478","8","1779","1790","isVersionOf https://doi.org/10.1007/s11010-022-04637-4","36571650","000904010400001","http://escholarship.lib.okayama-u.ac.jp/64309","10.1007/s11010-022-04637-4"
    "Kosuke;Ochi|Ken;Suzawa|Yin Min;Thu|Fumiaki;Takatsu|Shimpei;Tsudaka|Yidan;Zhu|Kentaro;Nakata|Tatsuaki;Takeda|Kazuhiko;Shien|Hiromasa;Yamamoto|Mikio;Okazaki|Seiichiro;Sugimoto|Tadahiko;Shien|Yoshiharu;Okamoto|Shuta;Tomida|Shinichi;Toyooka|","Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast","Cancer Science","1347-9032","2022-07-24","2022","","","","isVersionOf https://doi.org/10.1111/cas.15502","35871750","000840374000001","https://ousar.lib.okayama-u.ac.jp/63856","10.1111/cas.15502"
    "Miwa;Fujihara|Tadahiko;Shien|Kazuhiko;Shien|Ken;Suzawa|Tatsuaki;Takeda|Yidan;Zhu|Tomoka;Mamori|Yusuke;Otani|Ryo;Yoshioka|Maya;Uno|Yoko;Suzuki|Yuko;Abe|Minami;Hatono|Takahiro;Tsukioki|Yuko;Takahashi|Mariko;Kochi|Takayuki;Iwamoto|Naruto;Taira|Hiroyoshi;Doihara|Shinichi;Toyooka|","YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development","International Journal Of Molecular Sciences","1422-0067","2021-11-26","22","23","12809","","isVersionOf https://doi.org/10.3390/ijms222312809","34884609","000735641400001","https://ousar.lib.okayama-u.ac.jp/63082","10.3390/ijms222312809"
    "Kosuke;Ochi|Ken;Suzawa|Shuta;Tomida|Kazuhiko;Shien|Jui;Takano|Shunsaku;Miyauchi|Tatsuaki;Takeda|Akihiro;Miura|Kota;Araki|Kentaro;Nakata|Hiromasa;Yamamoto|Mikio;Okazaki|Seiichiro;Sugimoto|Tadahiko;Shien|Masaomi;Yamane|Kazuo;Azuma|Yoshiharu;Okamoto|Shinichi;Toyooka|","Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer","Biochemical and Biophysical Research Communications","0006-291X","2020-08-27","529","3","760","765","iaVersionOf https://doi.org/10.1016/j.bbrc.2020.06.077","32736704","000555780500037","https://ousar.lib.okayama-u.ac.jp/60396","10.1016/j.bbrc.2020.06.077"
    "Tatsuaki;Takeda|Hiromasa;Yamamoto|Ken;Suzawa|Shuta;Tomida|Shunsaku;Miyauchi|Kota;Araki|Kentaro;Nakata|Akihiro;Miura|Kei;Namba|Kazuhiko;Shien|Junichi;Soh|Tadahiko;Shien|Yoshihisa;Kitamura|Toshiaki;Sendo|Shinichi;Toyooka|","YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancers","Cancer Science","1347-9032","2019-12-19","111","3","849","856","isVersionOf https://doi.org/10.1111/cas.14289","31856375","000507433400001","http://escholarship.lib.okayama-u.ac.jp/58246","10.1111/cas.14289"